MetLife, Inc. (MET) Price/FCF Ratio: 3.47
Is MetLife, Inc.’s Price/FCF ratio high or low?
MetLife, Inc.'s Price/FCF ratio of 3.47 is 11% below its 5-year average of 3.91, near the low end of its 5-year range (2.49–5.84).
The Price/FCF ratio for MetLife, Inc. (MET) is 3.47. It is above its 12-month average by 7.83% (3.22).
MET Price/FCF Ratio Chart
MET Average Price/FCF Ratio Chart
MET Current vs Average Price/FCF Ratio Chart
MET Price/FCF Ratio Metrics
PRICE/FCF RATIO
3.47
PRICE/FCF RATIO AVG TTM
3.22
PRICE/FCF RATIO AVG 3Y
3.78
PRICE/FCF RATIO AVG 5Y
3.91
PRICE/FCF RATIO AVG 10Y
3.84
PRICE/FCF RATIO AVG 15Y
3.61
PRICE/FCF RATIO AVG 20Y
4.79
CURRENT VS TTM AVG
+7.83%
CURRENT VS 3Y AVG
-8.31%
CURRENT VS 5Y AVG
-11.24%
CURRENT VS 10Y AVG
-9.62%
CURRENT VS 15Y AVG
-3.80%
CURRENT VS 20Y AVG
-27.52%
MET Competitors' Price/FCF Ratio
| NAME | MARKET CAP | PRICE/FCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| MetLife, Inc. (MET) | $56.35B | 3.47 | 3.22 | 3.78 | 3.91 |
| Arthur J. Gallagher & Co. (AJG) | $57.28B | 31.12 | 34.62 | 33.74 | 31.10 |
| The Allstate Corporation (ALL) | $57.72B | 5.11 | 5.97 | 7.22 | 7.41 |
| Aflac Incorporated (AFL) | $59.74B | 20.59 | 22.59 | 18.53 | 14.57 |
| Discover Financial Services (DFS) | $50.34B | 5.96 | 4.50 | 4.21 | 4.56 |
| The Travelers Companies, Inc. (TRV) | $64.72B | 5.81 | 6.34 | 6.32 | 6.14 |
| State Street Corporation (STT) | $44.78B | N/A | 13.98 | 8.63 | 9.54 |
| State Street SPDR Dow Jones Industrial Average ETF Trust (DIA) | $44.24B | N/A | N/A | N/A | N/A |
| MSCI Inc. (MSCI) | $44.05B | 28.93 | 29.31 | 33.35 | 38.96 |
| Coinbase Global, Inc. (COIN) | $40.56B | 14.60 | 88.57 | 52.35 | 33.50 |
Free Cash Flow Valuation
P/FCF Ratio
3.5
FCF Yield
28.82%
MetLife, Inc. Price/FCF Ratio Formula & Definition
P/FCF measures market price relative to free cash flow per share. Free cash flow is operating cash flow after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
MetLife, Inc. Price/FCF Ratio FAQ
- What is the Price/FCF ratio for MetLife, Inc. (MET)?
- The Price/FCF ratio for MET stock is 3.47.
- Is MetLife, Inc.'s Price/FCF ratio high or low?
- MetLife, Inc.'s Price/FCF ratio of 3.47 is 11% below its 5-year average of 3.91, near the low end of its 5-year range (2.49–5.84).
- What is the TTM average Price/FCF ratio for MetLife, Inc. (MET)?
- The TTM average Price/FCF ratio for MET stock is 3.22.
- What is the 3Y average Price/FCF ratio for MetLife, Inc. (MET)?
- The 3Y average Price/FCF ratio for MET stock is 3.78.
- What is the 5Y average Price/FCF ratio for MetLife, Inc. (MET)?
- The 5Y average Price/FCF ratio for MET stock is 3.91.
- What is the 10Y average Price/FCF ratio for MetLife, Inc. (MET)?
- The 10Y average Price/FCF ratio for MET stock is 3.84.
- What is the 15Y average Price/FCF ratio for MetLife, Inc. (MET)?
- The 15Y average Price/FCF ratio for MET stock is 3.61.
- What is the 20Y average Price/FCF ratio for MetLife, Inc. (MET)?
- The 20Y average Price/FCF ratio for MET stock is 4.79.
MetLife, Inc. Price/FCF Ratio History
| DATE | PRICE/FCF RATIO |
|---|---|
| 2026-06-10 | 3.47 |
| 2026-06-09 | 3.39 |
| 2026-06-08 | 3.35 |
| 2026-06-05 | 3.35 |
| 2026-06-04 | 3.31 |
| 2026-06-03 | 3.21 |
| 2026-06-02 | 3.29 |
| 2026-06-01 | 3.25 |
| 2026-05-29 | 3.28 |
| 2026-05-28 | 3.25 |
| 2026-05-27 | 3.30 |
| 2026-05-26 | 3.30 |
| 2026-05-22 | 3.33 |
| 2026-05-21 | 3.34 |
| 2026-05-20 | 3.27 |
| 2026-05-19 | 3.22 |
| 2026-05-18 | 3.23 |
| 2026-05-15 | 3.16 |
| 2026-05-14 | 3.14 |
| 2026-05-13 | 3.10 |
| 2026-05-12 | 3.12 |
| 2026-05-11 | 3.09 |
| 2026-05-08 | 3.10 |
| 2026-05-07 | 3.13 |
| 2026-05-06 | 2.94 |
| 2026-05-05 | 2.93 |
| 2026-05-04 | 2.90 |
| 2026-05-01 | 2.95 |
| 2026-04-30 | 2.94 |
| 2026-04-29 | 2.90 |
| 2026-04-28 | 2.88 |
| 2026-04-27 | 2.85 |
| 2026-04-24 | 2.85 |
| 2026-04-23 | 2.79 |
| 2026-04-22 | 2.83 |
| 2026-04-21 | 2.85 |
| 2026-04-20 | 2.85 |
| 2026-04-17 | 2.87 |
| 2026-04-16 | 2.83 |
| 2026-04-15 | 2.85 |
| 2026-04-14 | 2.79 |
| 2026-04-13 | 2.77 |
| 2026-04-10 | 2.71 |
| 2026-04-09 | 2.74 |
| 2026-04-08 | 2.73 |
| 2026-04-07 | 2.62 |
| 2026-04-06 | 2.61 |
| 2026-04-02 | 2.60 |
| 2026-04-01 | 2.61 |
| 2026-03-31 | 2.60 |
| 2026-03-30 | 2.51 |
| 2026-03-27 | 2.49 |
| 2026-03-26 | 2.56 |
| 2026-03-25 | 2.59 |
| 2026-03-24 | 2.57 |
| 2026-03-23 | 2.54 |
| 2026-03-20 | 2.52 |
| 2026-03-19 | 2.52 |
| 2026-03-18 | 2.52 |
| 2026-03-17 | 2.55 |
| 2026-03-16 | 2.54 |
| 2026-03-13 | 2.50 |
| 2026-03-12 | 2.53 |
| 2026-03-11 | 2.57 |
| 2026-03-10 | 2.59 |
| 2026-03-09 | 2.60 |
| 2026-03-06 | 2.64 |
| 2026-03-05 | 2.68 |
| 2026-03-04 | 2.69 |
| 2026-03-03 | 2.67 |
| 2026-03-02 | 2.69 |
| 2026-02-27 | 2.65 |
| 2026-02-26 | 2.79 |
| 2026-02-25 | 2.77 |
| 2026-02-24 | 2.77 |
| 2026-02-23 | 2.76 |
| 2026-02-20 | 2.91 |
| 2026-02-19 | 2.87 |
| 2026-02-18 | 3.50 |
| 2026-02-17 | 3.47 |
| 2026-02-13 | 3.42 |
| 2026-02-12 | 3.42 |
| 2026-02-11 | 3.49 |
| 2026-02-10 | 3.44 |
| 2026-02-09 | 3.37 |
| 2026-02-06 | 3.37 |
| 2026-02-05 | 3.33 |
| 2026-02-04 | 3.45 |
| 2026-02-03 | 3.40 |
| 2026-02-02 | 3.53 |
| 2026-01-30 | 3.48 |
| 2026-01-29 | 3.46 |
| 2026-01-28 | 3.37 |
| 2026-01-27 | 3.39 |
| 2026-01-26 | 3.41 |
| 2026-01-23 | 3.35 |
| 2026-01-22 | 3.40 |
| 2026-01-21 | 3.38 |
| 2026-01-20 | 3.34 |
| 2026-01-16 | 3.39 |
| 2026-01-15 | 3.44 |
| 2026-01-14 | 3.47 |
| 2026-01-13 | 3.41 |
| 2026-01-12 | 3.46 |
| 2026-01-09 | 3.51 |
| 2026-01-08 | 3.52 |
| 2026-01-07 | 3.46 |
| 2026-01-06 | 3.59 |
| 2026-01-05 | 3.61 |
| 2026-01-02 | 3.55 |
| 2025-12-31 | 3.49 |
| 2025-12-30 | 3.52 |
| 2025-12-29 | 3.53 |
| 2025-12-26 | 3.55 |
| 2025-12-24 | 3.58 |
| 2025-12-23 | 3.57 |
| 2025-12-22 | 3.59 |
| 2025-12-19 | 3.60 |
| 2025-12-18 | 3.61 |
| 2025-12-17 | 3.65 |
| 2025-12-16 | 3.64 |
| 2025-12-15 | 3.65 |
| 2025-12-12 | 3.63 |
| 2025-12-11 | 3.63 |
| 2025-12-10 | 3.53 |
| 2025-12-09 | 3.44 |
| 2025-12-08 | 3.45 |
| 2025-12-05 | 3.48 |
| 2025-12-04 | 3.45 |
| 2025-12-03 | 3.42 |
| 2025-12-02 | 3.37 |
| 2025-12-01 | 3.37 |
| 2025-11-28 | 3.38 |
| 2025-11-26 | 3.37 |
| 2025-11-25 | 3.35 |
| 2025-11-24 | 3.32 |
| 2025-11-21 | 3.32 |
| 2025-11-20 | 3.27 |
| 2025-11-19 | 3.30 |
| 2025-11-18 | 3.33 |
| 2025-11-17 | 3.34 |
| 2025-11-14 | 3.47 |
| 2025-11-13 | 3.51 |
| 2025-11-12 | 3.54 |
| 2025-11-11 | 3.44 |
| 2025-11-10 | 3.41 |
| 2025-11-07 | 3.36 |
| 2025-11-06 | 3.36 |
| 2025-11-05 | 3.37 |
| 2025-11-04 | 3.41 |
| 2025-11-03 | 3.40 |
| 2025-10-31 | 3.42 |
| 2025-10-30 | 3.39 |
| 2025-10-29 | 3.36 |
| 2025-10-28 | 3.38 |
| 2025-10-27 | 3.38 |
| 2025-10-24 | 3.37 |
| 2025-10-23 | 3.35 |
| 2025-10-22 | 3.37 |
| 2025-10-21 | 3.39 |
| 2025-10-20 | 3.38 |
| 2025-10-17 | 3.36 |
| 2025-10-16 | 3.34 |
| 2025-10-15 | 3.50 |
| 2025-10-14 | 3.55 |
| 2025-10-13 | 3.46 |
| 2025-10-10 | 3.42 |
| 2025-10-09 | 3.51 |
| 2025-10-08 | 3.52 |
| 2025-10-07 | 3.55 |
| 2025-10-06 | 3.53 |
| 2025-10-03 | 3.53 |
| 2025-10-02 | 3.49 |
| 2025-10-01 | 3.51 |
| 2025-09-30 | 3.53 |
| 2025-09-29 | 3.52 |
| 2025-09-26 | 3.50 |
| 2025-09-25 | 3.44 |
| 2025-09-24 | 3.46 |
| 2025-09-23 | 3.44 |
| 2025-09-22 | 3.47 |
| 2025-09-19 | 3.39 |
| 2025-09-18 | 3.39 |
| 2025-09-17 | 3.37 |
| 2025-09-16 | 3.37 |
| 2025-09-15 | 3.45 |
| 2025-09-12 | 3.46 |
| 2025-09-11 | 3.44 |
| 2025-09-10 | 3.40 |
| 2025-09-09 | 3.40 |
| 2025-09-08 | 3.41 |
| 2025-09-05 | 3.41 |
| 2025-09-04 | 3.50 |
| 2025-09-03 | 3.45 |
| 2025-09-02 | 3.45 |
| 2025-08-29 | 3.49 |
| 2025-08-28 | 3.46 |
| 2025-08-27 | 3.48 |
| 2025-08-26 | 3.47 |
| 2025-08-25 | 3.46 |
| 2025-08-22 | 3.49 |
| 2025-08-21 | 3.40 |
| 2025-08-20 | 3.39 |
| 2025-08-19 | 3.37 |
| 2025-08-18 | 3.33 |
| 2025-08-15 | 3.31 |
| 2025-08-14 | 3.34 |
| 2025-08-13 | 3.32 |
| 2025-08-12 | 3.28 |
| 2025-08-11 | 3.23 |
| 2025-08-08 | 3.27 |
| 2025-08-07 | 3.16 |
| 2025-08-06 | 3.06 |
| 2025-08-05 | 3.02 |
| 2025-08-04 | 3.02 |
| 2025-08-01 | 2.98 |
| 2025-07-31 | 3.06 |
| 2025-07-30 | 3.01 |
| 2025-07-29 | 3.13 |
| 2025-07-28 | 3.13 |
| 2025-07-25 | 3.17 |
| 2025-07-24 | 3.13 |
| 2025-07-23 | 3.16 |
| 2025-07-22 | 3.12 |
| 2025-07-21 | 3.08 |
| 2025-07-18 | 3.11 |
| 2025-07-17 | 3.12 |
| 2025-07-16 | 3.09 |
| 2025-07-15 | 3.07 |
| 2025-07-14 | 3.14 |
| 2025-07-11 | 3.13 |
| 2025-07-10 | 3.16 |
| 2025-07-09 | 3.15 |
| 2025-07-08 | 3.21 |
| 2025-07-07 | 3.19 |
| 2025-07-03 | 3.25 |
| 2025-07-02 | 3.23 |
| 2025-07-01 | 3.27 |
| 2025-06-30 | 3.24 |
| 2025-06-27 | 3.24 |
| 2025-06-26 | 3.22 |
| 2025-06-25 | 3.19 |
| 2025-06-24 | 3.21 |
| 2025-06-23 | 3.21 |
| 2025-06-20 | 3.19 |
| 2025-06-18 | 3.17 |
| 2025-06-17 | 3.14 |
| 2025-06-16 | 3.16 |
| 2025-06-13 | 3.12 |
| 2025-06-12 | 3.18 |
| 2025-06-11 | 3.18 |
| 2025-06-10 | 3.20 |
| 2025-06-09 | 3.21 |
| 2025-06-06 | 3.22 |
| 2025-06-05 | 3.17 |
| 2025-06-04 | 3.18 |
| 2025-06-03 | 3.20 |
| 2025-06-02 | 3.17 |
| 2025-05-30 | 3.17 |
| 2025-05-29 | 3.18 |
Showing the most recent 260 of 5,031 data points. The chart above shows the full history.
Related Metrics
About MetLife, Inc.
MetLife, Inc. operates as a leading global financial services entity, delivering an extensive array of services encompassing insurance, annuities, employee benefits, and asset management. The company manages its operations through five primary divisions: the U.S., Asia, Latin America, Europe, the Middle East and Africa (EMEA), and MetLife Holdings. Its broad insurance offerings include life, dental, group short-term and long-term disability, individual disability, pet, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans. MetLife also supports employers with administrative services-only (ASO) arrangements. Furthermore, it provides sophisticated financial instruments such as general and separate account contracts, synthetic guaranteed interest contracts, and private floating rate funding agreements. The company facilitates pension risk transfers, offers institutional income annuities, structures settlements, and delivers capital markets investment products. Specialized life insurance products and funding agreements are also available for post-retirement benefits, alongside company, bank, or trust-owned life insurance used to finance non-qualified executive benefit programs. In addition, MetLife offers a variety of annuity options including fixed, indexed-linked, and variable, alongside pension and regular savings products. Its life insurance portfolio features whole life, term life, endowments, universal and variable life, and group life policies. The company also provides longevity reinsurance solutions, credit insurance products, and protection for long-term healthcare services. MetLife, Inc. was founded in 1863 and is headquartered in New York City.
- Sector
- Financial Services
- Industry
- Insurance - Life
- CEO
- Michel Abbas Khalaf